SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-069083
Filing Date
2023-12-08
Accepted
2023-12-08 16:50:30
Documents
9
Period of Report
2023-12-08

Document Format Files

Seq Description Document Type Size
1 6-K underwriting_agreement.htm 6-K 32728
2 EX-1.1 phvs-ex1_1.htm EX-1.1 355498
3 EX-4.1 phvs-ex4_1.htm EX-4.1 125490
4 EX-5.1 phvs-ex5_1.htm EX-5.1 119489
5 EX-5.2 phvs-ex5_2.htm EX-5.2 21940
6 GRAPHIC img250002415_0.jpg GRAPHIC 8836
7 GRAPHIC img250002415_1.jpg GRAPHIC 8836
8 GRAPHIC img250925936_0.jpg GRAPHIC 43956
9 GRAPHIC img250925936_1.jpg GRAPHIC 22956
  Complete submission text file 0000950170-23-069083.txt   773201
Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000 31 (0)71 203 6410
Pharvaris N.V. (Filer) CIK: 0001830487 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40010 | Film No.: 231476089
SIC: 2834 Pharmaceutical Preparations